New and worsening otologic symptoms are a side effect of teprotumumab

Investigators at a single center in the United States reviewed real-world patient data on otologic issues related to teprotumumab treatment for thyroid eye disease.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553